The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage <i>P. falciparum</i> Parasites, DMPK Properties, and the Case for Artemiside
Because of the need to replace the current clinical artemisinins in artemisinin combination therapies, we are evaluating fitness of amino-artemisinins for this purpose. These include the thiomorpholine derivative artemiside obtained in one scalable synthetic step from dihydroartemisinin (DHA) and th...
Main Authors: | Liezl Gibhard, Dina Coertzen, Janette Reader, Mariëtte E. van der Watt, Lyn-Marie Birkholtz, Ho Ning Wong, Kevin T. Batty, Richard K. Haynes, Lubbe Wiesner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/12/2066 |
Similar Items
-
Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue
by: Jerome P. L. Ng, et al.
Published: (2022-09-01) -
Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies–Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites
by: Ho Ning Wong, et al.
Published: (2020-01-01) -
The current use of the artemisinin-based Combination Therapies in adult patients at a Tertiary Hospital, South-South Nigeria
by: STEPHEN AYINBUOMWAN, et al.
Published: (2022-12-01) -
The current use of the artemisinin-based Combination Therapies in adult patients at a Tertiary Hospital, South-South Nigeria
by: STEPHEN AYINBUOMWAN, et al.
Published: (2022-12-01) -
Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)